title: Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: relationship with steatosis.
authors.forename: Gianni
authors.initials: G
authors.lastname: Testino
authors.forename: Alessandro
authors.initials: A
authors.lastname: Sumberaz
authors.forename: Gianluigi
authors.initials: G
authors.lastname: Ravetti
authors.forename: Raffaella
authors.initials: R
authors.lastname: Gentile
authors.forename: Filippo
authors.initials: F
authors.lastname: Ansaldi
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Icardi
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D004359:Drug Therapy, Combination; D005234:Fatty Liver / Q000097:blood*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014280:Triglycerides; D012254:Ribavirin; D002784:Cholesterol